Novo CEO pressed by Senate to chop costs of weight problems, diabetic issues medications CEO Lars Fruergaard Jørgensen explained to lawmakers the corporation would think about new talks with insurers with regard to the record price ranges of Wegovy and copyright whenever they pledge to maintain the medicines on their https://arizona-hard-tea-carbs88542.affiliatblogger.com/82774347/details-fiction-and-healthcare-news